about
Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in ratsBiotinylated liposomes as potential carriers for the oral delivery of insulin.Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinideA Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats.Core-shell nanocarriers with high paclitaxel loading for passive and active targeting.Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicityCytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.Globular protein-coated Paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics.Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.Nanoemulsion-templated shell-crosslinked nanocapsules as drug delivery systems.Rod-Shaped Active Drug Particles Enable Efficient and Safe Gene Delivery.Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery.Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.Self-assembled nanoparticles from hyaluronic acid-paclitaxel prodrugs for direct cytosolic delivery and enhanced antitumor activity.Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.Design and optimization of gastro-floating sustained-release tablet of pregabalin: in vitro and in vivo evaluation.Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis.Green Synthesis of Carbon Nanotubes-Reinforced Molecularly Imprinted Polymer Composites for Drug Delivery of FenbufenAmorphous Nanosuspensions Aggregated from Paclitaxel⁻Hemoglobulin Complexes with Enhanced Cytotoxicity.Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in ratsFood proteins as novel nanosuspension stabilizers for poorly water-soluble drugsMatrix tablets for sustained release of repaglinide: Preparation, pharmacokinetics and hypoglycemic activity in beagle dogsControlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tabletA drug-delivering-drug strategy for combined treatment of metastatic breast cancerDrug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal routePotent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesisTargeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular RemodelingSustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs"Locked" cancer cells are more sensitive to chemotherapy
P50
Q34730028-1E652500-2287-437C-A92E-D21437E96264Q34869982-10CD6301-FADB-4141-9F39-3E1696D710ACQ35209974-499F2935-74A5-4CFA-8F68-01EC6CE44611Q36360531-4667E327-567A-4577-8199-AEF4BF80F79EQ36986079-16170B9E-B4F6-4225-BB1D-CA6E7EA6CEAEQ37718748-5EECD58A-2047-4EFB-857A-890418359962Q37739791-94C69DC1-9ED3-4467-AA8E-7D86857EC763Q38896301-5BB742DB-29FA-4949-8398-ECD362E38076Q38905402-FC385D36-B890-4545-BD1B-E8CA831DE789Q38926608-5287AB68-5139-4A1D-9B01-3C4E6F3B4373Q45385712-53A4DE76-D0E5-4B5E-9095-9DE570F74327Q45875385-66B9BFD4-B873-4A7C-8C08-D73E7F7977FDQ46139137-2D7D056F-450F-4926-B9C6-542B254D0BD7Q47836096-3AA3A87A-B0C7-4E27-8E49-A6E16F720308Q47910349-F520B9A0-1E4F-4F9B-B1D9-DA660A17A1B6Q47916527-9C83C9BD-FBFC-42AB-A7AE-8F365722A1CBQ48207998-4581F504-82C9-4789-B662-4261AC9AAD34Q49916854-AD3708BC-0483-45C0-8160-B48FC5D49E76Q51746684-94E579E8-070F-4739-87FF-56BE3425B2FCQ52591675-6CAC4122-512F-448D-A52A-D20A6BBCE08AQ55531515-9564100B-FBED-4C0D-AF48-A5F16570C67FQ57460681-A13F2570-8FB2-402E-9D4F-3D55E963FE74Q64965044-6A1F5187-906F-40F2-A08A-29EBE5BB4C32Q80794174-277E5CA1-9AFD-44B5-9AD4-37CFDD3A7AB2Q85569756-CF383290-CAA5-4E3A-87B8-3A93B630251CQ86080887-9A81B410-21C5-48B7-BFDE-3DA5FF6ED0A9Q87414513-A6A1A41E-9CBC-442B-8352-D45771605C61Q90024500-B3D21EF1-525D-4349-915F-F645DA64BDF9Q90352904-C2882C5E-28B6-458B-A5A3-0009DE98D835Q90862817-8A2173BE-92DA-4981-A2D7-1EDA630E082FQ91017261-C2135F1C-71B4-4D3C-994F-E42EDA7F11F8Q91182935-8E6B3C85-3F17-4169-AE4E-6C708B34C265Q93091714-FA19DC0B-703C-4FF8-B520-B5540CFFA500
P50
description
researcher (ORCID 0000-0003-3075-3831)
@en
name
Wei He
@en
type
label
Wei He
@en
prefLabel
Wei He
@en
P31
P496
0000-0003-3075-3831